Collaborations & Alliances
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Dyadic, Sanofi Enter Research Collaboration
To explore the potential of its C1 technology to produce multiple types of biologic vaccines and drugs of interest09.18.18
-
Bio News | Collaborations & Alliances | Industry News
Neurimmune Achieves Milestone in Ono Collaboration
Focused on the development of human-derived antibodies against a novel therapeutic target for neurodegenerative diseases09.18.18
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
AstraZeneca Joins Horizon's Genomics Discovery Initiative
Horizon Discovery's Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform09.18.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Fate & ONO Enter Development Collaboration
For the joint development and commercialization of two off-the-shelf CAR-T cell product candidates09.18.18
-
Breaking News | Capsules | Collaborations & Alliances | Packaging & Tracking
PCI, CSP Technologies in Exclusive Activ-Blister Alliance
To provide clinical trials and stability testing utilizing Activ-Blister packaging solutions09.17.18
-
Breaking News | Collaborations & Alliances | Drug Development
Agenus Achieves Incyte Milestone
Initiation of a Phase I trial of INCAGN2385 triggers $5M payment09.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Evotec AG, Almirall, S.A. Enter Collaboration
To discover and develop first-in-class therapeutics through a novel approach to disrupt cell signalling09.17.18
-
Bio News | Collaborations & Alliances | Industry News | Regulatory Affairs
Recipharm Receives EMVO Approval
The connection, facilitated by strategic partner TraceLink is to to submit serialization data to the European Hub09.13.18
-
Bio News | Collaborations & Alliances | Industry News
Cambrex Completes Halo Acquisition
Initially announced in July 2018, the deal closed for approximately $425 million09.12.18
-
Analytical Services | Bio News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology | Laboratory Testing | R&D
FloDesign, Cognate Announce Collaboration
To advance the development of life saving therapeutics by improving manufacturing efficiencies using FloDesign's ACP Platform09.12.18
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
Bloom Science, Biose industrie Enter Mfg. Agreement
For the manufacture development of Bloom Science's novel epilepsy Live Biotherapeutic Product (LBP)09.12.18
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Industry News | Process Development
Abzena Selects Sartorius as U.S. Equipment Supplier
Sartorius Stedim will equip Abzena's CDMO facilities in Bristol, PA and San Diego, CA with end-to-end process solutions09.12.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D | Trials & Filings
Boehringer Announces Positive Phase III Results
Confirmed that Cyltezo is equivalent to Humira, with no clinically meaningful differences in efficacy or safety09.12.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Athenex & Hanmi Realign Joint Projects
Changes were announced to the Orascovery Program and KX-01 Oral Formulation partnership09.12.18
-
Bio News | Collaborations & Alliances | Industry News | Laboratory Testing
NeoGenomics, Premier Enter Agreement
The group purchasing agreement is for the use of clinical reference laboratory testing services09.12.18
-
Bio News | Collaborations & Alliances | CRO News | Industry News
WDBMD Acquires DZS Clinical Services
WDBMD will enable DZS to bolster its full-service CRO capabilities and provide more comprehensive & global services09.10.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Trials & Filings
FDA Grants Amgen & AstraZeneca Breakthrough Therapy Designation
For tezepelumab in patients with severe asthma without an eosinophilic phenotype09.07.18
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
Avara Acquires Sterile Mfg. Facility from Sandoz
The Boucherville, Quebec sterile manufacturing and development center is the largest of its kind in Canada09.07.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D | Trials & Filings
Gilead, Galapagos Announce Positive Phase 2 Results
In the TORTUGA study of filgotinib, an investigational, selective JAK1 inhibitor for the treatment of ankylosing spondylitis09.06.18
-
Collaborations & Alliances | Drug Discovery
Pfizer, CYTOO in Research and Option Agreement
Aims to develop a target discovery platform for Duchenne Muscular Dystrophy09.06.18
